Provenge Immunotherapy for Prostate Cancer

Join Allan J. Pantuck, MD, MS, FACS, professor in the UCLA Department of Urology as he discusses the use of Provenge in the treatment of prostate cancer. Dr. Pantuck will discuss the background and rationale for the use of immune-based therapies in the treatment of cancer and the indications, benefits and side effects of Provenge.